PYRIDOSTIGMINE BROMIDE ORAL

PYRIDOSTIGMINE BROMIDE ORAL was reported 3554 times

PYRIDOSTIGMINE BROMIDE ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL MYASTHENIC SYNDROME 14 0.6667
1 EYE LUXATION 4 0.1176
2 MYASTHENIA GRAVIS CRISIS 170 0.1146
3 BORDERLINE LEPROSY 4 0.1026
4 BLOOD BROMIDE INCREASED 2 0.0952
5 MYIASIS 5 0.0806
6 THYMECTOMY 6 0.0682
7 AIRWAY COMPRESSION 2 0.0541
8 MYASTHENIA GRAVIS 437 0.0541
9 BULBAR PALSY 13 0.0469
10 REVERSIBLE SPLENIAL LESION SYNDROME 3 0.0469
11 MYASTHENIC SYNDROME 36 0.0465
12 MORPHOEA 17 0.0351
13 OCULAR MYASTHENIA 12 0.0350
14 AUTONOMIC FAILURE SYNDROME 2 0.0345
15 ACUTE ON CHRONIC LIVER FAILURE 6 0.0278
16 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 6 0.0263
17 NEISSERIA INFECTION 3 0.0236
18 SUPINE HYPERTENSION 4 0.0212
19 CEREBRAL TOXOPLASMOSIS 18 0.0193
20 HEPATITIS B SURFACE ANTIBODY POSITIVE 5 0.0171
21 CHARLES BONNET SYNDROME 2 0.0167
22 MENINGOCOCCAL SEPSIS 3 0.0158
23 CRYPTOCOCCAL MENINGOENCEPHALITIS 2 0.0153
24 MILLER FISHER SYNDROME 3 0.0134
25 HEPATITIS B CORE ANTIBODY POSITIVE 5 0.0133
26 DROPPED HEAD SYNDROME 5 0.0127
27 CHOLINERGIC SYNDROME 8 0.0125
28 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 3 0.0124
29 RESPIRATORY MUSCLE WEAKNESS 4 0.0123
30 OROMANDIBULAR DYSTONIA 9 0.0123
31 SINOATRIAL BLOCK 7 0.0117
32 ENCEPHALITIS BRAIN STEM 2 0.0116
33 THYMOMA 4 0.0111
34 PULMONARY NOCARDIOSIS 9 0.0109
35 HYPERADRENOCORTICISM 3 0.0109
36 HERPES ZOSTER OTICUS 5 0.0099
37 TRANSFUSION-RELATED ACUTE LUNG INJURY 3 0.0097
38 CORONARY ARTERY ANEURYSM 2 0.0085
39 ERYTHROMELALGIA 3 0.0082
40 HEPATOSPLENIC T-CELL LYMPHOMA 3 0.0081
41 METASTASES TO PLEURA 8 0.0076
42 HUMAN HERPESVIRUS 8 INFECTION 4 0.0066
43 EXTRAOCULAR MUSCLE PARESIS 3 0.0065
44 EYELID PTOSIS 66 0.0065
45 SARS-COV-2 ANTIBODY TEST NEGATIVE 3 0.0063
46 NOCARDIOSIS 15 0.0059
47 TRACHEAL DISORDER 3 0.0058
48 ANION GAP DECREASED 2 0.0057
49 HISTOPLASMOSIS 10 0.0056
50 CORYNEBACTERIUM INFECTION 3 0.0056
51 GLUCOSE TOLERANCE IMPAIRED 33 0.0056
52 B-CELL LYMPHOMA RECURRENT 3 0.0055
53 LISTERIOSIS 6 0.0054
54 BRAIN STEM SYNDROME 4 0.0053
55 STENOTROPHOMONAS INFECTION 7 0.0052
56 ORTHOSTATIC HYPERTENSION 3 0.0051
57 OPHTHALMOPLEGIA 8 0.0051
58 ANAL ULCER 4 0.0049
59 LICHENOID KERATOSIS 11 0.0048
60 GASTROINTESTINAL HYPERMOTILITY 2 0.0047
61 PRODUCT NAME CONFUSION 5 0.0046
62 AXONAL NEUROPATHY 4 0.0046
63 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 6 0.0044
64 HISTOPLASMOSIS DISSEMINATED 7 0.0044
65 MACROCYTOSIS 5 0.0043
66 H1N1 INFLUENZA 6 0.0043
67 TORTICOLLIS 9 0.0042
68 PNEUMOCYSTIS JIROVECII INFECTION 5 0.0042
69 STEROID DIABETES 6 0.0040
70 IMMUNE-MEDIATED ENCEPHALITIS 2 0.0038
71 CORNEAL EROSION 2 0.0037
72 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 4 0.0036
73 BOTULISM 3 0.0036
74 BACTERIURIA 2 0.0035
75 INTESTINAL PSEUDO-OBSTRUCTION 3 0.0034
76 ANOGENITAL WARTS 3 0.0034
77 VARICELLA 8 0.0033
78 NUCHAL RIGIDITY 3 0.0033
79 PNEUMONIA PSEUDOMONAL 5 0.0033
80 ARTERIOSPASM CORONARY 13 0.0032
81 PULPITIS DENTAL 3 0.0032
82 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 7 0.0031
83 CUSHINGOID 10 0.0031
84 CRYPTOCOCCOSIS 5 0.0031
85 BICYTOPENIA 6 0.0031
86 SUSPECTED COVID-19 10 0.0030
87 VENOUS THROMBOSIS LIMB 6 0.0029
88 SPUTUM INCREASED 6 0.0028
89 THYROTOXIC CRISIS 3 0.0026
90 MASTICATION DISORDER 8 0.0026
91 DIPLOPIA 67 0.0026
92 REBOUND EFFECT 29 0.0026
93 ATRIOVENTRICULAR BLOCK COMPLETE 17 0.0025
94 ANTICHOLINERGIC SYNDROME 4 0.0025
95 HAEMOPERITONEUM 2 0.0025
96 PRETERM PREMATURE RUPTURE OF MEMBRANES 3 0.0025
97 STRONGYLOIDIASIS 4 0.0025
98 ALTERED VISUAL DEPTH PERCEPTION 2 0.0024
99 ARTHRITIS BACTERIAL 10 0.0024
100 CARTILAGE INJURY 6 0.0024
101 TONSILLAR HYPERTROPHY 4 0.0024
102 BRAIN ABSCESS 6 0.0024
103 CEREBRAL VENOUS SINUS THROMBOSIS 2 0.0024
104 THERAPY PARTIAL RESPONDER 36 0.0023
105 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 3 0.0023
106 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
107 VOCAL CORD PARALYSIS 4 0.0022
108 ANAEMIA OF CHRONIC DISEASE 2 0.0022
109 INFUSION SITE RASH 3 0.0022
110 CHORIORETINOPATHY 3 0.0021
111 FACIAL ASYMMETRY 2 0.0021
112 NOROVIRUS INFECTION 3 0.0021
113 DYSPNOEA AT REST 6 0.0021
114 DEVICE RELATED THROMBOSIS 2 0.0020
115 AUTONOMIC NEUROPATHY 2 0.0020
116 CONSCIOUSNESS FLUCTUATING 2 0.0019
117 MEDICATION RESIDUE PRESENT 9 0.0019
118 EXOPHTHALMOS 4 0.0019
119 OSTEOPENIA 28 0.0018
120 ACINETOBACTER INFECTION 2 0.0018
121 GASTROINTESTINAL ULCER 4 0.0018
122 AORTIC DILATATION 2 0.0018
123 DEMENTIA WITH LEWY BODIES 2 0.0018
124 MENINGITIS ASEPTIC 8 0.0018
125 GASTROINTESTINAL ULCER HAEMORRHAGE 2 0.0018
126 MYOPATHY 15 0.0017
127 THERAPY NON-RESPONDER 78 0.0017
128 MENINGITIS CRYPTOCOCCAL 3 0.0017
129 STRIDOR 5 0.0017
130 HYPERTENSIVE EMERGENCY 2 0.0017
131 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 3 0.0017
132 SYMPTOM RECURRENCE 10 0.0017
133 PNEUMOMEDIASTINUM 3 0.0017
134 FEBRILE CONVULSION 2 0.0016
135 CEREBROSPINAL FLUID LEAKAGE 3 0.0016
136 BLOOD ELECTROLYTES ABNORMAL 2 0.0016
137 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
138 INTERVERTEBRAL DISCITIS 3 0.0016
139 LIP DISORDER 3 0.0016
140 BILE DUCT STONE 5 0.0016
141 INCREASED BRONCHIAL SECRETION 4 0.0016
142 FAILURE TO THRIVE 8 0.0015
143 CYTOMEGALOVIRUS CHORIORETINITIS 3 0.0015
144 BACTERIAL SEPSIS 5 0.0015
145 PERSONALITY DISORDER 4 0.0015
146 RESPIRATORY ACIDOSIS 6 0.0015
147 HIRSUTISM 2 0.0015
148 COMPRESSION FRACTURE 8 0.0015
149 SUBDURAL HAEMORRHAGE 4 0.0015
150 CORNEAL ABRASION 2 0.0015
151 ENTEROCOCCAL INFECTION 7 0.0014
152 COVID-19 PNEUMONIA 17 0.0014
153 MUSCLE FATIGUE 6 0.0014
154 CATAPLEXY 2 0.0014
155 BLOOD ELECTROLYTES DECREASED 2 0.0014
156 FIBULA FRACTURE 4 0.0014
157 LYMPHOPROLIFERATIVE DISORDER 4 0.0014
158 FEELING DRUNK 10 0.0013
159 RESPIRATORY FAILURE 98 0.0013
160 LYMPHOPENIA 19 0.0013
161 DIVERTICULUM INTESTINAL HAEMORRHAGIC 3 0.0013
162 PARAESTHESIA ORAL 19 0.0013
163 BRAIN OPERATION 3 0.0013
164 GASTROSTOMY 2 0.0013
165 NORMAL NEWBORN 7 0.0013
166 ESCHERICHIA BACTERAEMIA 3 0.0013
167 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
168 FUNGAEMIA 2 0.0013
169 EYE OEDEMA 3 0.0012
170 WALKING AID USER 8 0.0012
171 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 4 0.0012
172 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 66 0.0012
173 GASTROINTESTINAL TUBE INSERTION 3 0.0012
174 GASTRIC DILATATION 2 0.0012
175 TACHYPNOEA 16 0.0012
176 GAZE PALSY 2 0.0012
177 SKIN HYPERPIGMENTATION 10 0.0012
178 CERVICAL SPINAL STENOSIS 2 0.0012
179 ACUTE RESPIRATORY FAILURE 22 0.0011
180 FACIAL PARESIS 4 0.0011
181 ANAL FISTULA 6 0.0011
182 EPSTEIN-BARR VIRUS INFECTION 7 0.0011
183 DEVICE ALARM ISSUE 2 0.0011
184 ISCHAEMIA 5 0.0011
185 LUNG CONSOLIDATION 3 0.0011
186 ENDOTRACHEAL INTUBATION 3 0.0011
187 INTESTINAL PERFORATION 12 0.0011
188 SKIN HYPERTROPHY 3 0.0011
189 VENTRICULAR EXTRASYSTOLES 11 0.0011
190 NEUTROPHILIA 6 0.0011
191 INSURANCE ISSUE 16 0.0010
192 HYPOREFLEXIA 2 0.0010
193 REHABILITATION THERAPY 4 0.0010
194 CONVERSION DISORDER 2 0.0010
195 URINE OUTPUT DECREASED 9 0.0010
196 LUMBAR SPINAL STENOSIS 3 0.0010
197 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
198 DIPLEGIA 2 0.0010
199 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 5 0.0010
200 MYOSITIS 9 0.0010
201 SALIVARY HYPERSECRETION 10 0.0010
202 PNEUMOCYSTIS JIROVECII PNEUMONIA 10 0.0010
203 HEPATITIS B 6 0.0010
204 CENTRAL VENOUS CATHETERISATION 3 0.0010
205 MUSCLE DISORDER 8 0.0010
206 SPINAL FUSION SURGERY 4 0.0010
207 CHANGE OF BOWEL HABIT 2 0.0010
208 DIASTOLIC DYSFUNCTION 3 0.0010
209 DYSARTHRIA 36 0.0010
210 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
211 HEPATITIS B REACTIVATION 3 0.0009
212 VENTRICULAR HYPOKINESIA 3 0.0009
213 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
214 PRODUCT RESIDUE PRESENT 5 0.0009
215 HYPERPROLACTINAEMIA 6 0.0009
216 MUSCULAR WEAKNESS 105 0.0009
217 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
218 ORTHOSTATIC HYPOTENSION 16 0.0009
219 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
220 WHEELCHAIR USER 4 0.0009
221 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
222 IDIOPATHIC INTRACRANIAL HYPERTENSION 2 0.0009
223 DIABETIC RETINOPATHY 3 0.0009
224 BLOOD LOSS ANAEMIA 2 0.0009
225 EUPHORIC MOOD 9 0.0009
226 MYOCARDITIS 10 0.0009
227 EXERCISE TOLERANCE DECREASED 5 0.0009
228 EYELID DISORDER 2 0.0009
229 SYRINGE ISSUE 15 0.0009
230 DYSPHAGIA 81 0.0009
231 JOINT DISLOCATION 9 0.0009
232 THERAPEUTIC RESPONSE SHORTENED 28 0.0008
233 FIBRIN D DIMER INCREASED 3 0.0008
234 PRE-ECLAMPSIA 4 0.0008
235 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
236 PYODERMA GANGRENOSUM 3 0.0008
237 DRUG-INDUCED LIVER INJURY 26 0.0008
238 MENTAL STATUS CHANGES 23 0.0008
239 SCLERODERMA 3 0.0008
240 SPONDYLITIS 3 0.0008
241 CHOKING 16 0.0008
242 HAEMATOLOGICAL INFECTION 2 0.0008
243 GLOMERULONEPHRITIS 2 0.0008
244 FREEZING PHENOMENON 3 0.0008
245 CYTOKINE RELEASE SYNDROME 16 0.0008
246 AUTOIMMUNE THYROIDITIS 3 0.0008
247 HAEMORRHAGE URINARY TRACT 2 0.0008
248 ANGLE CLOSURE GLAUCOMA 2 0.0008
249 ENDOCARDITIS 4 0.0008
250 DISSEMINATED TUBERCULOSIS 2 0.0008
251 INCREASED UPPER AIRWAY SECRETION 4 0.0008
252 RIB FRACTURE 16 0.0008
253 MALABSORPTION 4 0.0008
254 ASPERGILLUS INFECTION 5 0.0008
255 RESPIRATORY DISTRESS 21 0.0008
256 PNEUMONIA ASPIRATION 19 0.0008
257 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 22 0.0008
258 HEPATIC ENCEPHALOPATHY 7 0.0007
259 AREFLEXIA 2 0.0007
260 MENINGITIS 5 0.0007
261 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
262 BRADYCARDIA 39 0.0007
263 GASTRIC PERFORATION 2 0.0007
264 CLONUS 2 0.0007
265 ASPIRATION 8 0.0007
266 ASTHENOPIA 4 0.0007
267 ON AND OFF PHENOMENON 4 0.0007
268 CHOLECYSTITIS INFECTIVE 2 0.0007
269 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
270 THERAPY CHANGE 7 0.0007
271 ATYPICAL FEMUR FRACTURE 2 0.0007
272 CHOLECYSTITIS ACUTE 4 0.0007
273 HYPOTONIA 7 0.0007
274 NEUTROPENIC SEPSIS 5 0.0007
275 HYPERTONIC BLADDER 2 0.0007
276 ESCHERICHIA SEPSIS 2 0.0007
277 STRESS CARDIOMYOPATHY 4 0.0007
278 SUBARACHNOID HAEMORRHAGE 7 0.0007
279 PERIPHERAL SENSORY NEUROPATHY 4 0.0007
280 TEMPERATURE INTOLERANCE 7 0.0007
281 CREPITATIONS 2 0.0007
282 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
283 VENTRICULAR TACHYCARDIA 11 0.0007
284 URINARY TRACT DISORDER 3 0.0007
285 LEUKOCYTOSIS 12 0.0007
286 EMERGENCY CARE 2 0.0007
287 EYE INJURY 2 0.0007
288 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
289 TROPONIN INCREASED 5 0.0007
290 OSTEOPOROSIS 27 0.0007
291 IMMUNE THROMBOCYTOPENIA 3 0.0007
292 DYSCHEZIA 2 0.0007
293 INTENTIONAL PRODUCT USE ISSUE 57 0.0007
294 UROSEPSIS 6 0.0006
295 POOR QUALITY SLEEP 14 0.0006
296 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
297 DELUSION 10 0.0006
298 BLOOD CREATININE DECREASED 2 0.0006
299 PHOTOPHOBIA 12 0.0006
300 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
301 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 45 0.0006
302 MUSCLE ATROPHY 8 0.0006
303 RENAL CYST 5 0.0006
304 HYPOVOLAEMIC SHOCK 3 0.0006
305 DRUG RESISTANCE 16 0.0006
306 INFUSION SITE PAIN 8 0.0006
307 RASH VESICULAR 3 0.0006
308 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
309 CARDIOMYOPATHY 9 0.0006
310 IMMUNE SYSTEM DISORDER 8 0.0006
311 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 5 0.0006
312 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
313 IMMUNODEFICIENCY 9 0.0006
314 HYPOAESTHESIA ORAL 9 0.0006
315 POST-TRAUMATIC STRESS DISORDER 4 0.0006
316 DRUG TOLERANCE 3 0.0006
317 WRONG PRODUCT ADMINISTERED 4 0.0006
318 BLOOD IRON DECREASED 7 0.0006
319 FACIAL PARALYSIS 5 0.0006
320 HYPERLIPIDAEMIA 7 0.0006
321 VITAMIN D DECREASED 5 0.0006
322 PRODUCT COLOUR ISSUE 3 0.0006
323 PSEUDOMONAS INFECTION 5 0.0006
324 APLASIA PURE RED CELL 2 0.0006
325 RESPIRATION ABNORMAL 4 0.0006
326 POOR VENOUS ACCESS 6 0.0006
327 BLOOD MAGNESIUM DECREASED 5 0.0006
328 DROOLING 4 0.0006
329 ENCEPHALITIS 4 0.0006
330 GRANULOMA 2 0.0006
331 NOCTURIA 7 0.0006
332 LARGE INTESTINE PERFORATION 4 0.0006
333 HYPERTRANSAMINASAEMIA 4 0.0006
334 BRAIN FOG 9 0.0006
335 CYANOSIS 9 0.0006
336 RESPIRATORY DEPRESSION 7 0.0006
337 PAPULE 4 0.0006
338 PNEUMOTHORAX 9 0.0006
339 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
340 PARALYSIS 8 0.0006
341 OVERWEIGHT 3 0.0006
342 OFF LABEL USE 488 0.0006
343 CONDITION AGGRAVATED 169 0.0006
344 HIP SURGERY 3 0.0006
345 OROPHARYNGEAL DISCOMFORT 5 0.0006
346 PULMONARY THROMBOSIS 6 0.0005
347 SPINAL FRACTURE 11 0.0005
348 INTESTINAL ISCHAEMIA 3 0.0005
349 DEAFNESS UNILATERAL 3 0.0005
350 NERVE COMPRESSION 5 0.0005
351 CYTOMEGALOVIRUS INFECTION 9 0.0005
352 GASTRIC INFECTION 2 0.0005
353 HERPES VIRUS INFECTION 3 0.0005
354 ATRIOVENTRICULAR BLOCK 4 0.0005
355 DYSTONIA 10 0.0005
356 PALLOR 14 0.0005
357 PELVIC FRACTURE 4 0.0005
358 AUTOIMMUNE DISORDER 5 0.0005
359 BASAL CELL CARCINOMA 8 0.0005
360 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
361 URINE ODOUR ABNORMAL 3 0.0005
362 HEAD DISCOMFORT 9 0.0005
363 ASTHENIA 191 0.0005
364 ULCER 8 0.0005
365 MACULAR DEGENERATION 6 0.0005
366 HYPERPHAGIA 2 0.0005
367 ABSCESS 8 0.0005
368 GASTROENTERITIS VIRAL 9 0.0005
369 SPEECH DISORDER 26 0.0005
370 FRUSTRATION TOLERANCE DECREASED 4 0.0005
371 BURSITIS 6 0.0005
372 ADRENAL INSUFFICIENCY 6 0.0005
373 INGUINAL HERNIA 3 0.0005
374 FEEDING DISORDER 10 0.0005
375 BONE MARROW FAILURE 10 0.0005
376 POST PROCEDURAL INFECTION 4 0.0005
377 SHOCK HAEMORRHAGIC 4 0.0005
378 ESCHERICHIA INFECTION 4 0.0005
379 LIMB DISCOMFORT 15 0.0005
380 SPINAL COMPRESSION FRACTURE 4 0.0005
381 ANOSMIA 7 0.0005
382 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
383 INFUSION SITE EXTRAVASATION 3 0.0005
384 NEEDLE ISSUE 14 0.0005
385 PRE-EXISTING CONDITION IMPROVED 3 0.0005
386 INJECTION SITE DISCOLOURATION 6 0.0005
387 COVID-19 84 0.0005
388 DYSPHONIA 28 0.0005
389 LIVE BIRTH 4 0.0005
390 INFUSION SITE SWELLING 3 0.0005
391 BLEPHAROSPASM 3 0.0005
392 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
393 SCAR 8 0.0005
394 HYPERGLYCAEMIA 17 0.0005
395 BLOOD POTASSIUM DECREASED 14 0.0005
396 HERNIA 9 0.0005
397 INCOHERENT 3 0.0005
398 DECREASED ACTIVITY 5 0.0005
399 HORDEOLUM 2 0.0005
400 SKIN SWELLING 4 0.0005
401 IMMOBILE 2 0.0005
402 DIVERTICULUM INTESTINAL 2 0.0005
403 HYPOGAMMAGLOBULINAEMIA 3 0.0005
404 INFECTION 66 0.0005
405 JOINT RANGE OF MOTION DECREASED 6 0.0004
406 MALNUTRITION 5 0.0004
407 HAEMOLYTIC ANAEMIA 4 0.0004
408 LOSS OF LIBIDO 4 0.0004
409 PSYCHOTIC DISORDER 13 0.0004
410 LEUKOPENIA 22 0.0004
411 PREMATURE DELIVERY 7 0.0004
412 HALLUCINATION 33 0.0004
413 CARDIAC ARREST 36 0.0004
414 RESPIRATORY DISORDER 13 0.0004
415 EYE OPERATION 2 0.0004
416 PRODUCT DISTRIBUTION ISSUE 4 0.0004
417 FEELING COLD 12 0.0004
418 COGNITIVE DISORDER 20 0.0004
419 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
420 AGITATION 31 0.0004
421 EXPOSURE DURING PREGNANCY 26 0.0004
422 CARDIOGENIC SHOCK 6 0.0004
423 IMPAIRED QUALITY OF LIFE 6 0.0004
424 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
425 HUMERUS FRACTURE 2 0.0004
426 ATELECTASIS 4 0.0004
427 GUILLAIN-BARRE SYNDROME 2 0.0004
428 HYPOKINESIA 6 0.0004
429 FAECES SOFT 3 0.0004
430 SEPSIS 46 0.0004
431 PHARYNGEAL SWELLING 4 0.0004
432 PSYCHIATRIC SYMPTOM 3 0.0004
433 BLOOD PRESSURE DECREASED 27 0.0004
434 SMALL INTESTINAL OBSTRUCTION 5 0.0004
435 HYPOPHOSPHATAEMIA 3 0.0004
436 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
437 LIMB INJURY 11 0.0004
438 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
439 ARTHROPOD BITE 3 0.0004
440 HYPERVOLAEMIA 2 0.0004
441 MATERNAL EXPOSURE DURING PREGNANCY 36 0.0004
442 CYST 5 0.0004
443 CELLULITIS 20 0.0004
444 HYPOTHERMIA 4 0.0004
445 PRODUCT DOSE OMISSION ISSUE 115 0.0004
446 SEPTIC SHOCK 17 0.0004
447 NEUTROPHIL COUNT INCREASED 4 0.0004
448 FEMORAL NECK FRACTURE 2 0.0004
449 MYDRIASIS 5 0.0004
450 PULMONARY EMBOLISM 37 0.0004
451 CACHEXIA 2 0.0004
452 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
453 OSTEOMYELITIS 7 0.0004
454 FOETAL DEATH 2 0.0004
455 HAEMORRHAGIC STROKE 3 0.0004
456 RESPIRATORY TRACT INFECTION 10 0.0004
457 HYPERSOMNIA 11 0.0004
458 TACHYCARDIA 34 0.0004
459 HALLUCINATION, VISUAL 8 0.0004
460 INCONTINENCE 4 0.0004
461 PRODUCT PRESCRIBING ERROR 9 0.0004
462 RENAL PAIN 4 0.0004
463 ADVERSE REACTION 5 0.0004
464 DYSSTASIA 11 0.0004
465 ATRIAL FLUTTER 3 0.0004
466 BLOOD PRESSURE FLUCTUATION 9 0.0004
467 FOOD POISONING 2 0.0004
468 LABORATORY TEST ABNORMAL 11 0.0004
469 LOCALISED INFECTION 9 0.0004
470 DYSPNOEA EXERTIONAL 14 0.0004
471 ATRIAL FIBRILLATION 36 0.0004
472 HYPOXIA 13 0.0004
473 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
474 SKIN LACERATION 4 0.0004
475 FEELING JITTERY 7 0.0004
476 PRODUCT PRESCRIBING ISSUE 8 0.0004
477 IMPAIRED GASTRIC EMPTYING 5 0.0004
478 IRRITABILITY 22 0.0004
479 POST PROCEDURAL COMPLICATION 7 0.0004
480 PERIPHERAL COLDNESS 5 0.0004
481 PARAESTHESIA 57 0.0004
482 DIVERTICULITIS 10 0.0004
483 VIRAL INFECTION 12 0.0004
484 LIP SWELLING 12 0.0004
485 FUNGAL INFECTION 12 0.0004
486 NERVE INJURY 4 0.0004
487 HEART RATE ABNORMAL 2 0.0004
488 MASS 5 0.0004
489 DISEASE RECURRENCE 17 0.0004
490 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
491 SKIN INFECTION 4 0.0004
492 OCULAR DISCOMFORT 4 0.0004
493 SKIN REACTION 5 0.0004
494 HEMIPARESIS 6 0.0004
495 STATUS EPILEPTICUS 4 0.0004
496 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 17 0.0004
497 IMPAIRED DRIVING ABILITY 4 0.0004
498 INTENTIONAL DOSE OMISSION 10 0.0004
499 THERAPY INTERRUPTED 25 0.0003
500 UNRESPONSIVE TO STIMULI 9 0.0003
501 LETHARGY 20 0.0003
502 PRODUCT SUBSTITUTION ISSUE 20 0.0003
503 MUSCLE STRAIN 3 0.0003
504 HYSTERECTOMY 3 0.0003
505 HYPERVENTILATION 2 0.0003
506 ELECTROLYTE IMBALANCE 4 0.0003
507 FALL 114 0.0003
508 HIP FRACTURE 11 0.0003
509 HYPOVOLAEMIA 2 0.0003
510 IMMUNOSUPPRESSION 3 0.0003
511 URINARY TRACT INFECTION 58 0.0003
512 LUNG INFILTRATION 3 0.0003
513 WEIGHT INCREASED 76 0.0003
514 HOSPITALISATION 52 0.0003
515 RESPIRATORY RATE INCREASED 3 0.0003
516 BACTERAEMIA 4 0.0003
517 CARDIOTOXICITY 3 0.0003
518 GASTROOESOPHAGEAL REFLUX DISEASE 27 0.0003
519 DRUG INTERACTION 53 0.0003
520 LACRIMATION INCREASED 10 0.0003
521 GAIT INABILITY 11 0.0003
522 PRESYNCOPE 8 0.0003
523 PNEUMONIA 106 0.0003
524 PNEUMONIA BACTERIAL 3 0.0003
525 PRODUCT USE IN UNAPPROVED INDICATION 81 0.0003
526 ANAPHYLACTIC REACTION 18 0.0003
527 MUSCLE SPASTICITY 4 0.0003
528 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
529 SURGERY 19 0.0003
530 BALANCE DISORDER 28 0.0003
531 DRUG INEFFECTIVE 425 0.0003
532 BACTERIAL INFECTION 6 0.0003
533 INFUSION RELATED REACTION 21 0.0003
534 SCIATICA 5 0.0003
535 HEART RATE DECREASED 11 0.0003
536 ENTERITIS 2 0.0003
537 MOVEMENT DISORDER 10 0.0003
538 HAEMOGLOBIN ABNORMAL 2 0.0003
539 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
540 INJECTION SITE INDURATION 4 0.0003
541 HERPES SIMPLEX 2 0.0003
542 PRODUCT AVAILABILITY ISSUE 7 0.0003
543 TREMOR 51 0.0003
544 MOBILITY DECREASED 22 0.0003
545 VITREOUS FLOATERS 3 0.0003
546 BEDRIDDEN 4 0.0003
547 PANCYTOPENIA 17 0.0003
548 HOSPICE CARE 3 0.0003
549 LIGAMENT SPRAIN 3 0.0003
550 SARS-COV-2 TEST POSITIVE 4 0.0003
551 CORONAVIRUS INFECTION 2 0.0003
552 INABILITY TO AFFORD MEDICATION 3 0.0003
553 APPETITE DISORDER 2 0.0003
554 CONTUSION 29 0.0003
555 ILLNESS 31 0.0003
556 BLOOD UREA INCREASED 5 0.0003
557 APHASIA 9 0.0003
558 GAIT DISTURBANCE 57 0.0003
559 JAUNDICE 8 0.0003
560 CANDIDA INFECTION 5 0.0003
561 DYSKINESIA 12 0.0003
562 SLUGGISHNESS 3 0.0003
563 ABDOMINAL DISCOMFORT 49 0.0003
564 EYE MOVEMENT DISORDER 2 0.0003
565 MUSCULOSKELETAL DISCOMFORT 5 0.0003
566 TREATMENT FAILURE 24 0.0003
567 TENDERNESS 3 0.0003
568 APHONIA 4 0.0003
569 FATIGUE 220 0.0003
570 DIVERTICULUM 2 0.0003
571 HEREDITARY ANGIOEDEMA 3 0.0003
572 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
573 RASH PRURITIC 15 0.0003
574 MYELODYSPLASTIC SYNDROME 4 0.0003
575 DIABETES MELLITUS 21 0.0003
576 FLUID OVERLOAD 4 0.0003
577 OSTEONECROSIS 9 0.0003
578 HYPOPHAGIA 7 0.0003
579 RESTLESSNESS 10 0.0003
580 FEBRILE NEUTROPENIA 18 0.0003
581 ACUTE MYOCARDIAL INFARCTION 8 0.0003
582 BLINDNESS TRANSIENT 2 0.0003
583 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
584 FOOT DEFORMITY 3 0.0003
585 URINARY RETENTION 9 0.0003
586 CATARACT 16 0.0003
587 PULMONARY MASS 4 0.0003
588 DYSPNOEA 152 0.0003
589 THERAPEUTIC RESPONSE UNEXPECTED 12 0.0003
590 THROAT IRRITATION 12 0.0003
591 MUSCLE SPASMS 49 0.0003
592 OXYGEN SATURATION DECREASED 15 0.0003
593 THERAPEUTIC RESPONSE DECREASED 16 0.0003
594 FOOT FRACTURE 5 0.0003
595 DERMATITIS CONTACT 3 0.0003
596 RHINORRHOEA 17 0.0003
597 PROTEINURIA 5 0.0003
598 INTERNAL HAEMORRHAGE 3 0.0003
599 MUSCULOSKELETAL STIFFNESS 23 0.0003
600 SLEEP APNOEA SYNDROME 5 0.0003
601 BLOOD PRESSURE INCREASED 40 0.0003
602 NEPHROLITHIASIS 12 0.0003
603 DEEP VEIN THROMBOSIS 17 0.0003
604 WEIGHT DECREASED 73 0.0003
605 NEOPLASM 3 0.0003
606 SEROTONIN SYNDROME 5 0.0003
607 GLAUCOMA 5 0.0003
608 THROAT TIGHTNESS 7 0.0003
609 DIARRHOEA 167 0.0003
610 EAR PAIN 5 0.0003
611 GASTROINTESTINAL DISORDER 23 0.0003
612 ADVERSE DRUG REACTION 23 0.0003
613 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
614 AFFECTIVE DISORDER 2 0.0003
615 CHEST DISCOMFORT 26 0.0003
616 HEAD INJURY 8 0.0003
617 SINUS DISORDER 5 0.0003
618 MYOCLONUS 3 0.0003
619 POLYNEUROPATHY 3 0.0003
620 DEMENTIA 7 0.0003
621 WRIST FRACTURE 3 0.0003
622 VISUAL IMPAIRMENT 31 0.0002
623 MYELOSUPPRESSION 9 0.0002
624 SENSORY DISTURBANCE 4 0.0002
625 PRODUCT PHYSICAL ISSUE 5 0.0002
626 MENTAL IMPAIRMENT 6 0.0002
627 HYPOAESTHESIA 37 0.0002
628 OEDEMA PERIPHERAL 30 0.0002
629 LIVER INJURY 6 0.0002
630 HERPES ZOSTER 14 0.0002
631 HYPERAESTHESIA 2 0.0002
632 TENDON RUPTURE 3 0.0002
633 STAPHYLOCOCCAL INFECTION 8 0.0002
634 GENERAL PHYSICAL HEALTH DETERIORATION 28 0.0002
635 THROMBOCYTOPENIA 27 0.0002
636 SLEEP DISORDER 17 0.0002
637 AGEUSIA 6 0.0002
638 HEMIPLEGIA 2 0.0002
639 EOSINOPHIL COUNT INCREASED 2 0.0002
640 SECRETION DISCHARGE 3 0.0002
641 BRAIN OEDEMA 3 0.0002
642 MOUTH ULCERATION 5 0.0002
643 URINARY INCONTINENCE 7 0.0002
644 FLUID RETENTION 12 0.0002
645 INJECTION SITE IRRITATION 3 0.0002
646 INTRAOCULAR PRESSURE INCREASED 3 0.0002
647 HEPATIC ENZYME INCREASED 16 0.0002
648 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
649 LIVER FUNCTION TEST INCREASED 5 0.0002
650 CARDIAC OPERATION 2 0.0002
651 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
652 PREMATURE BABY 7 0.0002
653 PARANOIA 4 0.0002
654 HAEMATOMA 6 0.0002
655 HYPERTENSION 49 0.0002
656 CARDIAC MURMUR 2 0.0002
657 ANAEMIA 44 0.0002
658 PRODUCT DOSE OMISSION 15 0.0002
659 PRODUCT DISPENSING ERROR 5 0.0002
660 LOCAL SWELLING 4 0.0002
661 DISEASE PROGRESSION 27 0.0002
662 GRIP STRENGTH DECREASED 2 0.0002
663 COLD SWEAT 4 0.0002
664 LOSS OF CONSCIOUSNESS 29 0.0002
665 VISION BLURRED 31 0.0002
666 HYPERHIDROSIS 29 0.0002
667 FACIAL PAIN 2 0.0002
668 THIRST 4 0.0002
669 THROMBOSIS 18 0.0002
670 QUALITY OF LIFE DECREASED 3 0.0002
671 ABDOMINAL PAIN UPPER 46 0.0002
672 GASTROINTESTINAL INFECTION 2 0.0002
673 PAIN OF SKIN 6 0.0002
674 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
675 SINUS CONGESTION 3 0.0002
676 CHILLS 26 0.0002
677 HEART RATE IRREGULAR 5 0.0002
678 OEDEMA 12 0.0002
679 FEELING ABNORMAL 53 0.0002
680 HYPOTHYROIDISM 7 0.0002
681 EXOSTOSIS 2 0.0002
682 CORONARY ARTERY OCCLUSION 3 0.0002
683 BRAIN NEOPLASM 2 0.0002
684 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 39 0.0002
685 PROCEDURAL PAIN 6 0.0002
686 PERICARDIAL EFFUSION 5 0.0002
687 POLLAKIURIA 9 0.0002
688 BACK PAIN 50 0.0002
689 HEPATIC STEATOSIS 4 0.0002
690 BLOOD CREATININE INCREASED 14 0.0002
691 THERAPY CESSATION 11 0.0002
692 CARPAL TUNNEL SYNDROME 3 0.0002
693 ILL-DEFINED DISORDER 13 0.0002
694 BLOOD TEST ABNORMAL 3 0.0002
695 INFLAMMATION 11 0.0002
696 HYPONATRAEMIA 12 0.0002
697 HEPATIC CIRRHOSIS 4 0.0002
698 NEUROPATHY PERIPHERAL 20 0.0002
699 BRONCHOSPASM 3 0.0002
700 SKIN DISORDER 7 0.0002
701 EYE INFLAMMATION 2 0.0002
702 HEADACHE 130 0.0002
703 DIZZINESS 103 0.0002
704 CONFUSIONAL STATE 33 0.0002
705 DEHYDRATION 27 0.0002
706 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
707 BLADDER DISORDER 2 0.0002
708 COLON CANCER 3 0.0002
709 DEVICE ISSUE 18 0.0002
710 RASH MACULAR 7 0.0002
711 MIGRAINE 19 0.0002
712 UNEVALUABLE EVENT 15 0.0002
713 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
714 HAEMATEMESIS 5 0.0002
715 SINUSITIS 20 0.0002
716 DEVICE RELATED INFECTION 3 0.0002
717 THYROID DISORDER 3 0.0002
718 ANKLE FRACTURE 3 0.0002
719 LUNG INFECTION 3 0.0002
720 DRUG EFFECT INCOMPLETE 7 0.0002
721 NERVOUS SYSTEM DISORDER 6 0.0002
722 ABDOMINAL DISTENSION 20 0.0002
723 URTICARIA 32 0.0002
724 NAUSEA 150 0.0002
725 RESPIRATORY TRACT CONGESTION 3 0.0002
726 OBESITY 3 0.0002
727 EAR INFECTION 5 0.0002
728 EATING DISORDER 4 0.0002
729 INSOMNIA 50 0.0002
730 NASAL CONGESTION 11 0.0002
731 HYPOGLYCAEMIA 9 0.0002
732 MUSCLE TIGHTNESS 3 0.0002
733 HAEMOGLOBIN DECREASED 19 0.0002
734 HYPOTENSION 37 0.0002
735 BACK INJURY 2 0.0002
736 PNEUMONITIS 5 0.0002
737 CHOLELITHIASIS 6 0.0002
738 EYE DISORDER 6 0.0002
739 DRUG LEVEL INCREASED 3 0.0002
740 DENTAL CARIES 2 0.0002
741 COAGULOPATHY 3 0.0002
742 AGGRESSION 9 0.0002
743 INFLUENZA 20 0.0002
744 NECK PAIN 10 0.0002
745 SOMNOLENCE 36 0.0002
746 EYE PAIN 10 0.0002
747 DISORIENTATION 7 0.0002
748 PAIN IN EXTREMITY 52 0.0002
749 DRUG INTOLERANCE 17 0.0002
750 PERIPHERAL SWELLING 27 0.0002
751 CHOLECYSTECTOMY 2 0.0002
752 SHOCK 4 0.0002
753 EPISTAXIS 13 0.0002
754 MUSCLE TWITCHING 4 0.0002
755 HYPOKALAEMIA 8 0.0002
756 DELIRIUM 6 0.0002
757 DRY MOUTH 14 0.0002
758 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
759 HEART RATE INCREASED 17 0.0002
760 INTENTIONAL OVERDOSE 11 0.0002
761 COUGH 48 0.0002
762 MYALGIA 29 0.0002
763 PANCREATITIS 9 0.0002
764 SWELLING FACE 11 0.0002
765 PRODUCTIVE COUGH 8 0.0002
766 RASH ERYTHEMATOUS 8 0.0002
767 HEPATITIS C 2 0.0002
768 PELVIC PAIN 3 0.0002
769 OSTEOARTHRITIS 7 0.0002
770 PANIC ATTACK 6 0.0002
771 FIBROMYALGIA 4 0.0002
772 INJECTION SITE URTICARIA 4 0.0002
773 ANXIETY 46 0.0002
774 GENERALISED OEDEMA 2 0.0002
775 FEMUR FRACTURE 5 0.0002
776 AGRANULOCYTOSIS 3 0.0002
777 ILEUS 2 0.0002
778 MIDDLE INSOMNIA 3 0.0002
779 DERMATITIS ALLERGIC 2 0.0002
780 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
781 COLITIS 6 0.0002
782 ACNE 12 0.0002
783 BLOOD URINE PRESENT 3 0.0002
784 MUSCULOSKELETAL DISORDER 3 0.0002
785 LOWER LIMB FRACTURE 3 0.0002
786 DRUG PRESCRIBING ERROR 3 0.0002
787 SEIZURE 18 0.0002
788 PRESCRIBED OVERDOSE 3 0.0002
789 NO ADVERSE EVENT 28 0.0002
790 HIATUS HERNIA 2 0.0002
791 MUCOSAL INFLAMMATION 4 0.0002
792 WHEEZING 9 0.0002
793 CONSTIPATION 33 0.0002
794 CHEST PAIN 28 0.0002
795 BLOOD PRESSURE ABNORMAL 3 0.0002
796 DECREASED APPETITE 35 0.0002
797 UPPER LIMB FRACTURE 3 0.0002
798 INJECTION SITE BRUISING 12 0.0002
799 PRESCRIBED UNDERDOSE 3 0.0002
800 CARDIAC FAILURE 12 0.0001
801 DEPRESSION 34 0.0001
802 BRONCHITIS 11 0.0001
803 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001
804 BLINDNESS 6 0.0001
805 VOMITING 69 0.0001
806 TREATMENT NONCOMPLIANCE 8 0.0001
807 LUNG NEOPLASM MALIGNANT 6 0.0001
808 MEMORY IMPAIRMENT 20 0.0001
809 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
810 RESPIRATORY ARREST 4 0.0001
811 HAEMATOCHEZIA 8 0.0001
812 HYPOMAGNESAEMIA 2 0.0001
813 MALAISE 63 0.0001
814 ROAD TRAFFIC ACCIDENT 6 0.0001
815 HAEMOPTYSIS 4 0.0001
816 COORDINATION ABNORMAL 2 0.0001
817 DERMATITIS 3 0.0001
818 DEVICE OCCLUSION 2 0.0001
819 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
820 DRY EYE 7 0.0001
821 ARTHRITIS 11 0.0001
822 LIVER FUNCTION TEST ABNORMAL 4 0.0001
823 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
824 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
825 APATHY 2 0.0001
826 PALPITATIONS 16 0.0001
827 DYSURIA 5 0.0001
828 PYREXIA 47 0.0001
829 PRURITUS 52 0.0001
830 STEVENS-JOHNSON SYNDROME 3 0.0001
831 HEPATOTOXICITY 3 0.0001
832 COLITIS ULCERATIVE 6 0.0001
833 HAEMORRHAGE 14 0.0001
834 RASH 58 0.0001
835 DERMATITIS ATOPIC 7 0.0001
836 DEPRESSED MOOD 7 0.0001
837 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
838 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
839 HIP ARTHROPLASTY 2 0.0001
840 INJECTION SITE SWELLING 10 0.0001
841 FEELING HOT 8 0.0001
842 INJECTION SITE RASH 4 0.0001
843 PAIN 80 0.0001
844 ADVERSE EVENT 12 0.0001
845 SYNCOPE 13 0.0001
846 OROPHARYNGEAL PAIN 12 0.0001
847 HYPERSENSITIVITY 24 0.0001
848 ABDOMINAL PAIN 30 0.0001
849 BURNING SENSATION 9 0.0001
850 SWELLING 12 0.0001
851 ARRHYTHMIA 6 0.0001
852 ERYTHEMA 26 0.0001
853 ABNORMAL BEHAVIOUR 5 0.0001
854 ARTHROPATHY 7 0.0001
855 INTENTIONAL PRODUCT MISUSE 11 0.0001
856 SKIN BURNING SENSATION 9 0.0001
857 CYSTITIS 4 0.0001
858 BLOOD GLUCOSE DECREASED 6 0.0001
859 BLISTER 7 0.0001
860 FLATULENCE 7 0.0001
861 NEURALGIA 3 0.0001
862 BLOOD POTASSIUM INCREASED 2 0.0001
863 BACK DISORDER 2 0.0001
864 ENCEPHALOPATHY 3 0.0001
865 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
866 RENAL FAILURE 16 0.0001
867 NASOPHARYNGITIS 22 0.0001
868 ERECTILE DYSFUNCTION 3 0.0001
869 GASTRIC DISORDER 4 0.0001
870 HYPOACUSIS 5 0.0001
871 DEVICE DEFECTIVE 2 0.0001
872 VAGINAL HAEMORRHAGE 5 0.0001
873 MENTAL DISORDER 5 0.0001
874 DISCOMFORT 7 0.0001
875 DEAFNESS 3 0.0001
876 SEDATION 3 0.0001
877 DEVICE USE ISSUE 2 0.0001
878 PRODUCT STORAGE ERROR 10 0.0001
879 GASTRITIS 3 0.0001
880 LIVER DISORDER 5 0.0001
881 CEREBROVASCULAR ACCIDENT 19 0.0001
882 CARDIAC FAILURE CONGESTIVE 9 0.0001
883 ACUTE KIDNEY INJURY 17 0.0001
884 FREQUENT BOWEL MOVEMENTS 3 0.0001
885 INJECTION SITE PAIN 34 0.0001
886 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
887 C-REACTIVE PROTEIN INCREASED 4 0.0001
888 BONE DISORDER 2 0.0001
889 END STAGE RENAL DISEASE 2 0.0001
890 UNDERDOSE 8 0.0001
891 MYOCARDIAL INFARCTION 19 0.0001
892 FLUSHING 11 0.0001
893 INJECTION SITE MASS 4 0.0001
894 CONJUNCTIVITIS 2 0.0001
895 AMNESIA 7 0.0001
896 BLOOD CHOLESTEROL INCREASED 5 0.0001
897 BLOOD SODIUM DECREASED 2 0.0001
898 ARTHRALGIA 44 0.0001
899 ANGINA PECTORIS 3 0.0001
900 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
901 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
902 HAEMORRHOIDS 2 0.0001
903 BONE PAIN 6 0.0001
904 LUNG DISORDER 5 0.0001
905 DISABILITY 2 0.0001
906 CORONARY ARTERY DISEASE 3 0.0001
907 SUICIDE ATTEMPT 6 0.0001
908 EXTRA DOSE ADMINISTERED 4 0.0001
909 PLEURAL EFFUSION 6 0.0001
910 DEVICE BREAKAGE 4 0.0001
911 VERTIGO 6 0.0001
912 ASTHMA 11 0.0001
913 EMOTIONAL DISORDER 3 0.0001
914 INFLUENZA LIKE ILLNESS 8 0.0001
915 PRODUCT USE ISSUE 18 0.0001
916 RENAL IMPAIRMENT 8 0.0001
917 RECTAL HAEMORRHAGE 4 0.0001
918 DISTURBANCE IN ATTENTION 5 0.0001
919 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
920 CHRONIC KIDNEY DISEASE 7 0.0001
921 INJECTION SITE PRURITUS 6 0.0001
922 TYPE 2 DIABETES MELLITUS 3 0.0001
923 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
924 CHROMATURIA 2 0.0001
925 INCORRECT DOSE ADMINISTERED 20 0.0001
926 HAEMATURIA 3 0.0001
927 INJECTION SITE REACTION 6 0.0001
928 SKIN DISCOLOURATION 4 0.0001
929 NEOPLASM PROGRESSION 3 0.0001
930 DEATH 74 0.0001
931 RENAL DISORDER 4 0.0001
932 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
933 DEVICE MALFUNCTION 6 0.0001
934 INJURY 6 0.0001
935 LYMPHADENOPATHY 3 0.0001
936 MULTIPLE SCLEROSIS 4 0.0001
937 DIABETIC KETOACIDOSIS 2 0.0001
938 ACCIDENTAL OVERDOSE 3 0.0001
939 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
940 EYE SWELLING 3 0.0001
941 HEPATIC FUNCTION ABNORMAL 3 0.0001
942 HOT FLUSH 6 0.0001
943 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
944 ANAPHYLACTIC SHOCK 2 0.0001
945 TOXICITY TO VARIOUS AGENTS 13 0.0001
946 APPLICATION SITE ERYTHEMA 2 0.0001
947 CARDIAC DISORDER 7 0.0001
948 FEAR 2 0.0001
949 EMOTIONAL DISTRESS 9 0.0001
950 BLOOD GLUCOSE INCREASED 14 0.0001
951 NEUTROPENIA 10 0.0001
952 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
953 MEDICATION ERROR 4 0.0001
954 WITHDRAWAL SYNDROME 3 0.0001
955 OVERDOSE 15 0.0001
956 EYE IRRITATION 4 0.0001
957 PULMONARY OEDEMA 3 0.0001
958 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
959 EPILEPSY 2 0.0001
960 OCULAR HYPERAEMIA 3 0.0001
961 COMA 3 0.0001
962 INTERSTITIAL LUNG DISEASE 3 0.0001
963 DRUG ABUSE 5 0.0001
964 NEOPLASM MALIGNANT 4 0.0001
965 NERVOUSNESS 3 0.0001
966 MUSCULOSKELETAL PAIN 3 0.0001
967 CRYING 2 0.0001
968 DYSGEUSIA 4 0.0001
969 PRODUCT QUALITY ISSUE 7 0.0001
970 DYSPEPSIA 5 0.0001
971 INJECTION SITE HAEMORRHAGE 4 0.0001
972 DRUG DOSE OMISSION 8 0.0000
973 CARDIO-RESPIRATORY ARREST 2 0.0000
974 SKIN EXFOLIATION 4 0.0000
975 DEVICE DISLOCATION 2 0.0000
976 PSORIASIS 6 0.0000
977 DEVICE DIFFICULT TO USE 3 0.0000
978 DRY SKIN 6 0.0000
979 RHEUMATOID ARTHRITIS 5 0.0000
980 SUICIDAL IDEATION 4 0.0000
981 JOINT SWELLING 5 0.0000
982 ALOPECIA 8 0.0000
983 INJECTION SITE ERYTHEMA 5 0.0000
984 ECZEMA 2 0.0000
985 DRUG EFFECT DECREASED 2 0.0000
986 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
987 DRUG WITHDRAWAL SYNDROME 3 0.0000
988 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
989 BREAST CANCER 2 0.0000
990 DRUG DEPENDENCE 3 0.0000